Blog
RSS FeedPosted by Michael Wonder on 10 Jul 2024
Updates to the HTA Policy and Methods Review
10 July 2024 - The Health Technology Assessment (HTA) Policy and Methods Review concluded on 4 May 2024. The HTA ...
Posted by Michael Wonder on 06 Jul 2024
Four decades of orphan drugs and priorities for the future
6 July 2024 - The Orphan Drug Act was enacted in the United States in 1983 in response to growing awareness ...
Posted by Michael Wonder on 03 Jul 2024
The rare paediatric disease voucher program creates new treatments. I have new data to prove it.
2 July 2024 - The FDA’s rare paediatric disease priority review voucher program, which has been providing incentives for lifesaving innovations ...
Posted by Michael Wonder on 05 Jun 2024
ICER publishes protocol for annual assessment of drug coverage policies that present barriers to fair access
5 June 2024 - This year’s analysis will include the top ten commercial formularies by covered lives, and include drugs ...
Posted by Michael Wonder on 31 May 2024
Annual report highlights progress in science, medicines and health in 2023
30 May 2024 - EMA’s annual report 2023 published today details the Agency’s contributions to public and animal health in the ...
Posted by Michael Wonder on 07 May 2024
Clinical benefit and regulatory outcomes of cancer drugs receiving accelerated approval
7 May 2024 - In this cohort study of cancer drugs granted accelerated approval from 2013 to 2017, 41% (19/46) did ...
Posted by Michael Wonder on 15 Apr 2024
Updates to the HTA Policy and Methods Review Reference Committee (15 April 2024)
15 April 2024 - The HTA Review Reference Committee is finalising its report and recommendations to the Australian Government having ...
Posted by Michael Wonder on 14 Apr 2024
HTA review - is today D day?
15 April 2024 - The review is due to be completed by 15 April 2024 (today). ...
Posted by Michael Wonder on 19 Mar 2024
Pharmac initiated lengthy review a waste of valuable time and resources, says Rare Disorders NZ
19 March 2024 - Rare Disorders NZ is very concerned that Pharmac will not extend access to life-saving medicines for ...
Posted by Michael Wonder on 07 Mar 2024
Pharmaceutical reform agreement review report
6 March 2024 - The Department of Health and Aged Care has conducted a review of Pharmaceutical Reform Agreements (PRAs), to ...
Posted by Michael Wonder on 04 Mar 2024
Findings from the Lean review of our drug reimbursement review program
29 February 2024 - Last year, CADTH communicated several improvements to our drug reimbursement review program, including a Lean review ...
Posted by Michael Wonder on 15 Feb 2024
Updates to the HTA review research and analysis papers collection: emerging health technologies
15 February 2024 - The draft paper 'Emerging Health Technologies' developed to support the deliberations of the HTA Review Reference ...
Posted by Michael Wonder on 06 Feb 2024
Updates to the HTA Review: consultation 2 survey
6 February 2024 - Access to the HTA Review Consultation 2 online survey is now available on the Office of ...
Posted by Michael Wonder on 29 Jan 2024
Updates to the HTA Review: options paper for Consultation 2 published
25 January 2024 - The Options paper for Consultation 2 is now available on the Office of Health Technology Assessment consultation ...
Posted by Michael Wonder on 18 Jan 2024
Updates to the HTA Policy and Methods Review Reference Committee (18 January 2024)
18 January 2024 - Communiques for three HTA Review Reference Committee meetings held in December 2023 are now available. ...